CDK14 and ovarian carcinoma: CDK14 reportedly participates in the proliferation and invasion of many tumor cells, including those of breast cancer (Imawari et al. 2018), glioma (Fan et al. 2015), hepatocellular carcinoma (Tu et al. 2019), and ovarian cancer (Ou-Yang et al. 2017).